APA ONLINE HOME HOME SITE MAP CONTACT
APA Online American Psychological Association
APA Home > Convention 2008 > Convention news


Medication shouldn’t be first choice for ADHD

The results of the largest-ever study on the best treatments for attention-deficit hyperactivity disorder have been widely misinterpreted to indicate that stimulant-based drugs are most effective in treating the disorder in children, researchers said Thursday at APA’s Annual Convention.

Research by William Pelham, PhD, of the State University of New York at Buffalo, and others shows that when children are treated with behavioral interventions -- and their parents are trained to better manage their children's behavior -- medication is used less often. And, when it is used, it's administered in much smaller doses, Pelham said.

“Medication should not play nearly as large a role as it does now in treatment of ADHD,” Pelham said.

That’s because while medications address ADHD symptoms such as restlessness and fidgeting in a classroom, they don’t address the impairments caused by ADHD. Those include a lack of successful interactions with peers, deficits in reading and math skills, and difficult relations with parents and family members.

Pelham also pointed out that researchers still don't know what long-term effects these medications may have. So far, research indicates that ingesting a large amount of drugs, particularly in higher doses over years of treatment in childhood, may reduce a child's adult height by two inches, Pelham said.


More information:

Read the PsycCentral article

 



Sponsor Links


Sponsor-related events


footer line
© 2008 American Psychological Association
750 First Street, N.E., Washington, DC, 20002-4242
Phone: 202-336-5700; TDD/TTY: 202-336-6123; Fax: 202-336-5708
PsychNET® | Terms of Use | Privacy Policy | Security | Advertise with us

 

Convention Home Registration Housing & Travel Programming Activities Exhibitors Contact Us news